Vesica Health is a privately held molecular diagnostics company based in Irvine, California, focused on precision medicine for urology and oncology. The company develops noninvasive, urine-based assays to improve the early detection and management of bladder cancer. Its core focus is on addressing the diagnostic gap for patients with hematuria (blood in the urine).
Company Values
Vesica Health stands out due to its flagship product, AssureMDx, having the highest reported accuracy for early-stage bladder cancer detection. The test has received FDA Breakthrough Device Designation, which prioritizes its review, and is recognized in American Urological Association (AUA) guidelines.